SMG
NAVB

Spectrum Management Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Spectrum Management Group’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45
Closed -$1K – 147
2014
Q3 		$1K Hold
45
– – ﹤0.01% 127
2014
Q2 		$1K Hold
45
– – ﹤0.01% 135
2014
Q1 		$2K Hold
45
– – ﹤0.01% 129
2013
Q4 		$2K Buy
+45
New +$1.76K ﹤0.01% 146

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Spectrum Management Group's NAVB Position: Q4 2014 in Review

Spectrum Management Group sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2014, closing a stake of 45 shares — an estimated $1K sold.

Spectrum Management Group first reported a position in NAVB in Q4 2013 and held it in 4 quarters. The position peaked at $2K in Q1 2014. 87 funds tracked by Wall St. Rank hold NAVB as of Q4 2014.

  • Spectrum Management Group reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Spectrum Management Group sold 45 Navidea Biopharmaceuticals Inc. shares in Q4 2014, an estimated $1K.
  • Spectrum Management Group first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2013 and held it in 4 quarters.
  • Spectrum Management Group's Navidea Biopharmaceuticals Inc. position peaked at $2K in Q1 2014.
  • 87 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2014.

Based on Spectrum Management Group's 13F filing for Q4 2014, filed 10 Feb 2015.